scholarly journals Indications and Limitations Associated with the Patency Capsule Prior to Capsule Endoscopy

Author(s):  
Masanao Nakamura ◽  
Hiroki Kawashima ◽  
Masatoshi Ishigami ◽  
Mitsuhiro Fujishiro
2012 ◽  
Vol 75 (4) ◽  
pp. AB261
Author(s):  
Thomas H. Smith ◽  
Achuthan Sourianarayanane ◽  
John J. Vargo ◽  
Jan Santisi ◽  
Cindy Heinlein ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
C. Römmele ◽  
J. Brueckner ◽  
H. Messmann ◽  
S. K. Gölder

Background.In patients with known or suspected risk factors for gastrointestinal stenosis, the PillCam patency capsule (PC) is given before a video capsule endoscopy (VCE) in order to minimize the risk of capsule retention (CR). CR is considered unlikely upon excretion of the PC within 30 hours, excretion in an undamaged state after 30 hours, or radiological projection to the colon.Methods.We performed a retrospective analysis of 38 patients with risk factors for CR, who received a PC from 02/2013 to 04/2015 at Klinikum Augsburg.Results.Sixteen of our 38 patients observed a natural excretion after a mean time of 34 hours past ingestion. However, only 8 patients observed excretion within 30 hours, as recommended by the company. In 20 patients passage of the PC into the colon was shown via RFID-scan or radiological imaging (after 33 and 45 hours, resp.). Only 2 patients showed a pathologic PC result. In consequence, 32 patients received the VCE; no CR was observed.Conclusion.Our data indicates that a VCE could safely be performed even if the PC excretion time is longer than 30 hours and the excreted PC was not screened for damage.


2004 ◽  
Vol 59 (5) ◽  
pp. P145
Author(s):  
Cristiano Spada ◽  
Gianluca Spera ◽  
Maria Elena Riccioni ◽  
Andrea Tringali ◽  
Pietro Familiari ◽  
...  

2005 ◽  
Vol 61 (5) ◽  
pp. AB162
Author(s):  
Michel Delvaux ◽  
Emmanuel Ben Soussan ◽  
Valerie Laurent ◽  
Eric Lerebours ◽  
Gerard Gay

2014 ◽  
Vol 15 (7) ◽  
pp. 345-351 ◽  
Author(s):  
Wei Zhang ◽  
Ze Long Han ◽  
Yang Cheng ◽  
Yang Zhi Xu ◽  
Kun Xiao ◽  
...  

2021 ◽  
Vol 12 (02) ◽  
pp. 071-077
Author(s):  
Hangyu Ji ◽  
Shaoli Wang ◽  
Yang Gong

Abstract Introduction The malfunction of capsule endoscopy (CE) devices is a significant reason for the failure of CE procedures, which could hinder and prevent diagnosis. Unfortunately, malfunction-related adverse events (AEs) caused by CE devices are rarely reported in publications. Although most malfunction-related AEs could not lead to physical harm, they could reduce the efficiency of medical care and increase medical costs. The manufacturer and user facility device experience (MAUDE) database, a publicly accessible resource for patient safety, contains not only the common complications of CE but also valuable malfunction-related AEs, which have been underutilized. Therefore, the study aims to discover and analyze the possible AEs associated with CE and demonstrate the utility of the MAUDE reports to promote patient safety. Materials and Methods We acquired MAUDE reports of CE systems from January 01, 2008, to July 31, 2020, through a systematic search strategy. We utilized the manufacturers, brand names, and product codes as search terms from which medical device reports including structured data and narrative texts were extracted, followed by a manual review of the narrative texts, reporter occupation, device involved, event type and the phase of the event; finally, patient outcomes were recorded and analyzed as per CE categories and characteristics. Results A total of 377 CEs medical device reports were retrieved, and 342 reports were included after reviewing. There were 327 mandatory reports (96%) and 15 voluntary reports (4%). These reports referred to capsule endoscope (n = 213), sensing system (n = 66), patency capsule (n = 38), and capsule delivery device (n = 26). A total of 349 CE-related AEs were identified, including complications (n = 228), malfunction-related AEs (n = 109), and other events (n = 12). The composition of AEs was not the same for the CE devices. Complications were major AEs of capsule endoscope and patency capsule, but malfunction-related AEs were the most common in AEs of sensing systems and capsule delivery devices. Conclusion MAUDE serves as an invaluable data source for investigating malfunction-related AEs. In addition to common complications, malfunction of CE devices could threaten patient safety in CE procedures. Improving awareness of the malfunction of CE devices and raising adequate training for staff working in gastrointestinal (GI) endoscopic units could be critical and beneficial in preventing malfunction-related AEs.


2021 ◽  
Author(s):  
Takahiro Miyazu ◽  
Satoshi Osawa ◽  
Satoshi Tamura ◽  
Shinya Tani ◽  
Natsuki Ishida ◽  
...  

Abstract In 2012, Japan approved the use of a tag-less patency capsule (PC), which evaluates gastrointestinal patency before small-bowel capsule endoscopy (SBCE). This study aimed to evaluate the validity of our modification on the passage criteria for this PC in clinical practice. We retrospectively enrolled 326 consecutive patients who underwent PC examination before SBCE. If X-ray could not reveal the PC in the body during the judgement time (30–33 h after ingestion), we defined it as ‘estimated patency’ and performed SBCE. We employed plain computed tomography (CT) for the second judgement, as needed. The overall patency rate was 95.1%. By X-ray, 41 (12.6%) patients were judged to have ‘estimated patency’, and SBCE could be safely performed. Plain CT judgement was necessary in 32.5%. One PC case had a residual coating film associated with stenosis in a patient with Crohn’s disease (CD), and one (0.3%) SBCE case had capsule retention resulting from false CT judgement. Multivariate analysis revealed that established CD and inpatient were factors related to patency loss. In conclusion, PC is useful for examining gastrointestinal patency, keeping in mind CT misjudgement. If PC was not found in the body via X-ray, performing SBCE as ‘estimated patency’ seemed appropriate.


Sign in / Sign up

Export Citation Format

Share Document